Envista (NYSE: NVST) revenue
Envista reported revenue of $2,720m for fiscal 2025, 8.3% more than in fiscal 2024 ($2,511m). Since fiscal 2017 its revenue has fallen by 3.3%, an average decline of 0.4% a year.
Envista's best year of the last 9 was fiscal 2018. The biggest drop was in fiscal 2019, −19.7%.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Revenue by fiscal year
| Fiscal year | Revenue | Change | Operating profit | Operating margin |
|---|---|---|---|---|
| 2025 | $2,720m | +8.3% | $216.1m | 7.9% |
| 2024 | $2,511m | −2.2% | −$1,038m | −41.4% |
| 2023 | $2,567m | −0.1% | $31.5m | 1.2% |
| 2022 | $2,569m | +2.4% | $319.2m | 12.4% |
| 2021 | $2,509m | +30.1% | $306.2m | 12.2% |
| 2020 | $1,929m | −15.6% | $43.5m | 2.3% |
| 2019 | $2,285m | −19.7% | $235.7m | 10.3% |
| 2018 | $2,845m | +1.2% | $298.4m | 10.5% |
| 2017 | $2,811m | — | $386.6m | 13.8% |
The change compares each fiscal year with the one before. Operating margin is operating profit over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Envista revenue compared with its sector
By revenue for its latest fiscal year, Envista ranks 97th of the 422 US health care companies with a page on Celsmar. The sector median grew 11.7% in its latest fiscal year; Envista, 8.3%.
| Rank | Company | Revenue | Revenue growth |
|---|---|---|---|
| 95th | Quidelortho | $2,730m | −1.9% |
| 96th | Fortrea | $2,723m | 1.0% |
| 97th | Envista | $2,720m | 8.3% |
| 98th | Insulet | $2,708m | 30.7% |
| 99th | BIO-RAD Laboratories | $2,583m | 0.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the revenue of Envista
- How much revenue did Envista make in fiscal 2025?
- Envista reported revenue of $2,720m for fiscal 2025, compared with $2,511m in fiscal 2024.
- How much has the revenue of Envista fallen?
- Between fiscal 2017 and fiscal 2025 it went from $2,811m to $2,720m: 3.3% less, an average decline of 0.4% a year.
- What was the best year for revenue at Envista?
- Of its last 9 fiscal years, fiscal 2018, with $2,845m.
- Where does Envista rank in its sector by revenue?
- It ranks 97th of the 422 US health care companies with a page on Celsmar, by revenue for its latest fiscal year.
- Where do the figures for Envista come from?
- From the annual report (Form 10-K) that Envista files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Envista files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017. More on Envista: the Envista page · annual accounts · net income · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.